Patients infected by hepatitis C virus (HCV) can be cured within 3 weeks of therapy using an NS3 protease inhibitor and dual NS5A inhibitor–NS5B nucleotide analogue - the so called 'direct acting antivirals (DAA)'! See the work published very recently: Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a …

Continue reading HCV patients can be cured within 3 weeks of therapy